EUVIMED · CrossrefZeitschrift
Metabolic Brain Disease
ISSN 0885-7490 · Springer Science and Business Media LLC
Neueste Artikel
Neutrophil extracellular traps in intracerebral hemorrhage: implications for pathogenesis and therapeutic targets
Neuroprotective effects of ivermectin against transient cerebral ischemia-reperfusion in rats
Regulation of oxygen–glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin
Impact of the metabolic syndrome on prevalence and survival in motor neuron disease: a retrospective case series
Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders
Membrane-stabilizing and protective effects of curcumin in a rotenone-induced rat model of Parkinson disease
Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury
Buckwheat tartary regulates the Gsk-3β/β-catenin pathway to prevent neurobehavioral impairments in a rat model of surgical menopause
Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models
New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis
Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine
Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics
Ameliorative effect of Brassica oleracea var. Italica extract on oxidative damage of arsenic in the rat’s brain: biochemical, pathological, and behavioral aspects
PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling
The curative and mechanistic acumen of curcuminoids formulations against haloperidol induced Parkinson’s disease animal model
D-beta-hydroxybutyrate protects against microglial activation in lipopolysaccharide-treated mice and BV-2 cells
Oxidative stress: a common imbalance in diabetes and epilepsy
Sarcococca saligna ameliorated D-galactose induced neurodegeneration through repression of neurodegenerative and oxidative stress biomarkers
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage
Emerging role of extracellular vesicles in the pathogenesis of glioblastoma
Brown adipose tissue and alzheimer’s disease
An aqueous macerate of Ziziphus jujuba reduces long-term spatial memory impairment in D-galactose treated rats: role of anti-inflammatory pathways
Effects of a novel probiotic mixture on the modulation of brain and intestine Aquaporin-4 gene expression in rats exposed to Cadmium
Effects of Capparis Spinosa extract on the neuropathic pain induced by chronic constriction injury in rats
Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy
Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease
Metabolomics of ischemic stroke: insights into risk prediction and mechanisms
Jahrgänge
2023 · 2202022 · 2362021 · 2172020 · 1332019 · 1642018 · 2072017 · 2232016 · 1622015 · 1682014 · 1152013 · 982012 · 702011 · 392010 · 552009 · 602008 · 412007 · 352006 · 312005 · 422004 · 402003 · 292002 · 522001 · 262000 · 471999 · 311998 · 351997 · 511996 · 341995 · 341994 · 321993 · 181992 · 191991 · 241990 · 211989 · 311988 · 291987 · 241986 · 26
EUVIMED